I think the most interesting thing about today's press release is that it feels like the kind of PR other company's release but that Cytodyn has actively avoided since the days of NP. Press releases are better than conference calls or investor letters, and it's felt like the company was handcuffed into only occasionally using the latter.

Maybe it's just because of the pressure investors have put on management and the board. Or pressure on the share price, which they seemingly have not cared about for two years. Maybe it's dumb luck and they just felt like it was time to update the investors.

Regardless, I'm glad they put this out as a PR and I hope they continue to keep us updated this way whenever reasonably (legally) possible.